For the year ending 2025-12-31, PRLD has $141,315K in assets. $72,678K in debts. $35,256K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 35,256 | |||
| Marketable securities | 67,958 | |||
| Prepaid expenses and other current assets | 2,478 | |||
| Total current assets | 105,692 | |||
| Restricted cash | 3,235 | |||
| Property, plant and equipment, gross | 12,042 | |||
| Less accumulated depreciation | 6,929 | |||
| Property and equipment, net | 5,113 | |||
| Right-of-use asset | 27,165 | |||
| Prepaid expenses and other non-current assets | 110 | |||
| Total assets | 141,315 | |||
| Accounts payable | 3,983 | |||
| Accrued expenses and other current liabilities | 12,533 | |||
| Deferred revenue | 33,734 | |||
| Operating lease liability | 2,744 | |||
| Finance lease liability | 0 | |||
| Total current liabilities | 52,994 | |||
| Deferred revenue, net of current portion | 1,798 | |||
| Other liabilities | 2,841 | |||
| Operating lease liability | 15,045 | |||
| Total liabilities | 72,678 | |||
| Common stock-Voting Common Stock | 5 | |||
| Common stock-Nonvoting Common Stock | 1 | |||
| Additional paid-in capital | 751,684 | |||
| Accumulated other comprehensive income | 8 | |||
| Accumulated deficit | -683,061 | |||
| Total stockholders equity | 68,637 | |||
| Total liabilities and stockholders equity | 141,315 | |||
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD)